137 related articles for article (PubMed ID: 7925784)
1. Therapeutic effects of nilvadipine on rat focal cerebral ischemia.
Li Y; Kawamura S; Yasui N; Shirasawa M; Fukasawa H
Exp Brain Res; 1994; 99(1):1-6. PubMed ID: 7925784
[TBL] [Abstract][Full Text] [Related]
2. Attenuated neuropathology by nilvadipine after middle cerebral artery occlusion in rats.
Kawamura S; Shirasawa M; Fukasawa H; Yasui N
Stroke; 1991 Jan; 22(1):51-5. PubMed ID: 1987673
[TBL] [Abstract][Full Text] [Related]
3. Effects of a Ca2+ entry blocker (nilvadipine) on acute focal cerebral ischemia in rats.
Kawamura S; Yasui N; Shirasawa M; Fukasawa H
Exp Brain Res; 1991; 83(2):434-8. PubMed ID: 2022249
[TBL] [Abstract][Full Text] [Related]
4. Effects of treatment with nilvadipine on cerebral ischemia in rats.
Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
Tohoku J Exp Med; 1998 Aug; 185(4):239-46. PubMed ID: 9865470
[TBL] [Abstract][Full Text] [Related]
5. [Ca++ antagonist and acute brain ischemia: effects of nilvadipine and nicardipine on middle cerebral artery occlusion in rats].
Shiino A; Matsuda M; Handa J; Morikawa S; Kido C; Inubushi T; Susumu T
Nihon Geka Hokan; 1991 Jan; 60(1):38-44. PubMed ID: 1819238
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
Neurol Med Chir (Tokyo); 1996 Mar; 36(3):151-5. PubMed ID: 8869150
[TBL] [Abstract][Full Text] [Related]
7. Effects of the calcium antagonist nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
Shiino A; Matsuda M; Susumu T; Handa J
Surg Neurol; 1991 Feb; 35(2):105-10. PubMed ID: 1990476
[TBL] [Abstract][Full Text] [Related]
8. Effects of nilvadipine (a dihydropyridine-type calcium entry blocker) on cerebral blood flow in acute experimental brain ischemia in rats.
Tanaka R; Miyasaka Y; Maruyama S; Nagai S; Fujii K
Neurol Res; 1996 Aug; 18(4):325-8. PubMed ID: 8875450
[TBL] [Abstract][Full Text] [Related]
9. Nilvadipine, a new calcium channel blocker, reduces ischemic brain injury in rats.
Takakura S; Susumu T; Satoh H; Mori J; Shiino A; Handa J
Jpn J Pharmacol; 1991 Aug; 56(4):547-50. PubMed ID: 1744995
[TBL] [Abstract][Full Text] [Related]
10. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
[TBL] [Abstract][Full Text] [Related]
11. Effects of nilvadipine on neuronal function in the ischemic cat brain.
Takakura S; Furuichi Y; Satoh H; Mori J; Kohsaka M
Surg Neurol; 1992 Apr; 37(4):255-60. PubMed ID: 1595035
[TBL] [Abstract][Full Text] [Related]
12. The role of strain/vendor differences on the outcome of focal ischemia induced by intraluminal middle cerebral artery occlusion in the rat.
Oliff HS; Weber E; Eilon G; Marek P
Brain Res; 1995 Mar; 675(1-2):20-6. PubMed ID: 7796130
[TBL] [Abstract][Full Text] [Related]
13. Postischemic (S)-emopamil therapy ameliorates focal ischemic brain injury in rats.
Morikawa E; Ginsberg MD; Dietrich WD; Duncan RC; Busto R
Stroke; 1991 Mar; 22(3):355-60. PubMed ID: 2003305
[TBL] [Abstract][Full Text] [Related]
14. Reduction of infarct size by intra-arterial nimodipine administered at reperfusion in a rat model of partially reversible brain focal ischemia.
Roda JM; Carceller F; Díez-Tejedor E; Avendaño C
Stroke; 1995 Oct; 26(10):1888-92. PubMed ID: 7570744
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.
Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345
[TBL] [Abstract][Full Text] [Related]
16. SB 201823-A antagonizes calcium currents in central neurons and reduces the effects of focal ischemia in rats and mice.
Barone FC; Lysko PG; Price WJ; Feuerstein G; al-Baracanji KA; Benham CD; Harrison DC; Harries MH; Bailey SJ; Hunter AJ
Stroke; 1995 Sep; 26(9):1683-9; discussion 1689-90. PubMed ID: 7660415
[TBL] [Abstract][Full Text] [Related]
17. Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats.
Belayev L; Busto R; Zhao W; Clemens JA; Ginsberg MD
J Neurosurg; 1997 Oct; 87(4):595-601. PubMed ID: 9322848
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of a dihydropyridine derivative, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarbox ylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester (CV-159), on rat ischemic brain injury.
Miyazaki H; Tanaka S; Fujii Y; Shimizu K; Nagashima K; Kamibayashi M; Uehara T; Okuma Y; Nomura Y
Life Sci; 1999; 64(10):869-78. PubMed ID: 10096437
[TBL] [Abstract][Full Text] [Related]
19. Infarct tolerance against temporary focal ischemia following spreading depression in rat brain.
Yanamoto H; Hashimoto N; Nagata I; Kikuchi H
Brain Res; 1998 Feb; 784(1-2):239-49. PubMed ID: 9518633
[TBL] [Abstract][Full Text] [Related]
20. Effective plasma concentration of a novel Na+/Ca2+ channel blocker NS-7 for its cerebroprotective actions in rats with a transient middle cerebral artery occlusion.
Aoki Y; Tamura M; Itoh Y; Seto T; Nonaka K; Mukai H; Ukai Y
J Pharmacol Exp Ther; 2001 Feb; 296(2):306-11. PubMed ID: 11160611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
